Related Experiment Videos
Immunology of leishmaniasis
1Department of Medicine and Microbiology, University of California, San Francisco Medical Centre 94143-0654.
Current Opinion in Immunology
|August 1, 1992
Summary
Effective leishmaniasis treatment relies on type 1 T helper cells to activate macrophages. Type 2 T helper cells worsen disease by deactivating macrophages, highlighting the importance of T-cell balance in fighting leishmaniasis.
Area of Science:
- Immunology
- Parasitology
- Cellular Biology
Background:
- Leishmaniasis resolution depends on specific T helper cell responses.
- Type 1 T helper cells activate macrophages to combat Leishmania parasites.
- Type 2 T helper cells exacerbate disease by counteracting protective immune mechanisms.
Purpose of the Study:
- To investigate the roles of T helper cells in leishmaniasis.
- To understand the mechanisms by which T cell subsets influence disease outcome.
- To characterize parasite molecules involved in the T cell response.
Main Methods:
- Analysis of T helper cell populations (Type 1 and Type 2) in a mouse model.
- Assessment of macrophage activation and microbicidal state.
- Investigation of lymphokine and cytokine activity.
- Characterization of parasite-derived antigens.
Main Results:
- Expansion of Type 1 T helper cells is crucial for parasite clearance.
- Expansion of Type 2 T helper cells exacerbates leishmaniasis in mice.
- Type 2 T helper cells inhibit macrophage activation via lymphokines.
- L-arginine-dependent nitrogen oxides mediate parasite destruction by macrophages.
Conclusions:
- Immune response balance, particularly between Type 1 and Type 2 T helper cells, is critical for controlling leishmaniasis.
- Understanding T cell subset functions and their secreted molecules is key to developing effective treatments.
- Further characterization of parasite antigens will aid in vaccine and therapeutic development.